1. "2015"
Formats
  1. Journal Article (2716)
  2. Meeting Abstract (1680)
  3. Book Section (364)
  4. Conference Paper (26)
  5. Book Whole (19)
  6. Review (2)
  7. Research Letter (1)
Groups
  1. Department of Medicine (1855)
  2. GSK Faculty (1116)
  3. Solid Tumor Oncology Division (1035)
  4. Surgery (883)
  5. Survivorship Research (752)
  6. Center for Hematologic Malignancies (746)

More Groups

People
  1. William Travis (102)
  2. Michael Berger (96)
  3. Clifford Hudis (85)
  4. Marc Ladanyi (79)
  5. Jedd Wolchok (68)
  6. Britta Weigelt (67)

More People

Years
  1. 2015 (4808)
Publications
  1. Journal of Clinical Oncology (475)
  2. Blood (224)
  3. Cancer Research (168)
  4. Modern Pathology (125)
  5. Laboratory Investigation (112)
  6. International Journal of Radiation Oncology, Biology, Physics (91)

More Publications

Publishers
  1. Elsevier Inc. (581)
  2. American Society of Clinical Oncology (508)
  3. Springer (380)
  4. Nature Publishing Group (301)
  5. American Association for Cancer Research (263)
  6. American Society of Hematology (228)

More Publishers

Results (4808)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • PRMT1-mediated methylation of DUSP4 determines megakaryocyte-erythroid lineage choice by regulating p38 signaling
    Meeting Abstract

    Su, H. R.; Tran, N. T.; Guo, H.; Luo, M.; Zhao, X. T.
    Blood (2015)

    Fulltext@MSK | Save
  • Updated efficacy and safety data from the AETHERA trial of consolidation with brentuximab vedotin after autologous stem cell transplant (ASCT) in Hodgkin lymphoma patients at high risk of relapse
    Meeting Abstract

    Sweetenham, J.; Walewski, J.; Nademanee, A. P.; Masszi, T.; Agura, E.; Holowiecki, J.; Abidi, M. H.; Chen, A. I.; Stiff, P.; Viviani, S.; more...
    Blood (2015)

    Fulltext@MSK | Save
  • Targeting CD99 in T-cell neoplasms with monoclonal antibodies
    Meeting Abstract

    Tavakkoli, M.; Lee, D. H.; Durham, B.; Chung, S. S.; Park, C. Y.
    Blood (2015)

    Fulltext@MSK | Save
  • Veliparib (ABT-888), bendamustine, and rituximab (VBR) is well tolerated and efficacious in patients with lymphoma: Final analysis of a phase 1b clinical trial of VB and a cohort expansion of VBR in patients with B-cell lymphoma
    Meeting Abstract

    Soumerai, J. D.; Zelenetz, A. D.; Moskowitz, C. H.; Younes, A.; Palomba, M. L.; Hamlin, P. A. Jr; Noy, A.; Horwitz, S. M.; Matasar, M. J.; Moskowitz, A. J.; more...
    Blood (2015)

    Fulltext@MSK | Save
  • Safety and clinical activity of atezolizumab (anti-PDL1) in combination with obinutuzumab in patients with relapsed or refractory non-Hodgkin lymphoma
    Meeting Abstract

    Till, B. G.; Park, S. I.; Popplewell, L. L.; Goy, A.; Penuel, E.; Venstrom, J. M.; Liu, B.; Fingerle-Rowson, G.; Byon, J.; Woodard, P.; more...
    Blood (2015)

    Fulltext@MSK | Save
  • Global 3' UTR sequencing in multiple myeloma (MM)
    Meeting Abstract

    Singh, I.; Samur, M. K.; Lee, S. H.; Sperling, A. S.; Tai, Y. T.; Fulciniti, M.; Leslie, C. S.; Mayr, C.; Munshi, N. C.
    Blood (2015)

    Fulltext@MSK | Save
  • RBM15-mediated RNA splicing fine-tunes epigenetic program through interaction with SF3B1
    Meeting Abstract

    Tran, N. T.; Su, H. R.; Lu, Y. H.; Leslie, C. S.; Zhao, X. Y.
    Blood (2015)

    Fulltext@MSK | Save
  • Autologous hematopoietic stem cell transplantation overcomes primary refractory disease in multiple myeloma patients treated with novel agents
    Meeting Abstract

    Shah, G. L.; Hsu, M.; Devlin, S.; Chung, D. J.; Hassoun, H.; Koehne, G.; Korde, N. S.; Lendvai, N.; Lesokhin, A. M.; Landgren, O.; more...
    Blood (2015)

    Fulltext@MSK | Save
  • Long-term follow up of pediatric patients with Hodgkin lymphoma treated with high dose therapy and autologous stem cell transplantation
    Meeting Abstract

    Roth, L. G.; O'Donohue, T.; Trippett, T.; Klein, E.; Kernan, N. A.; Kobos, R.; Prockop, S.; Scaradavou, A.; Shukla, N.; Steinherz, P. G.; more...
    Blood (2015)

    Fulltext@MSK | Save
  • A detailed evaluation of transplant-related toxicities and outcome for patients with CNS lymphoma (CNSL) consolidated with high-dose therapy and autologous stem cell transplantation (HDT-ASCT) using thiotepa, busulfan (Bu), cyclophosphamide (TBC) conditioning
    Meeting Abstract

    Scordo, M.; Bhatt, V.; Hsu, M.; Omuro, A. M.; Matasar, M. J.; DeAngelis, L.; Dahi, P. B.; Moskowitz, C. H.; Giralt, S. A.; Sauter, C. S.
    Blood (2015)

    Fulltext@MSK | Save